XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss $ (71,812) $ (53,518)
Adjustments to reconcile net loss to net cash, cash equivalents and restricted cash used in operating activities:    
Loss on issuance of financial instruments 64,049 674
Change in fair value of financial instruments (34,075) 27,372
Stock-based compensation 9,435 4,477
Depreciation 123 132
Noncash lease expenses 364 319
Noncash interest expense 344 0
Changes in operating assets and liabilities:    
Inventories (872) 0
Prepaid and other assets (853) (985)
Accounts payable 1,697 (478)
Accrued expenses and other liabilities (563) (4,176)
Accrued compensation 2,274 (665)
Operating lease liabilities (39) (378)
Net cash, cash equivalents and restricted cash used in operating activities (29,928) (27,226)
Cash flows from investing activities:    
Proceeds from sale of Softcup line of business 250 250
Maturities of short-term investments 8,233 0
Purchases of property and equipment (536) 0
Net cash, cash equivalents and restricted cash provided by investing activities 7,947 250
Cash flows from financing activities:    
Proceeds from issuance of common stock - exercise of warrants 2 6,273
Proceeds from issuance of common stock, warrants and purchase rights in connection with the 2019 Private Placement, net of financial advisory fees 0 75,400
Proceeds from issuance of common stock, net of discounts and commissions - Public Offering 103,738 0
Proceeds from issuance of common stock, net of commissions - ATM transactions 3,781 0
Proceeds from issuance of common stock - ESPP and exercise of stock options 337 46
Borrowings under convertible notes 25,000 0
Short-swing profit disgorgement 173 0
Repayment of Vendor Note 0 (4,010)
Cash paid for financing costs (317) (890)
Payments for tax withholdings related to vesting of restricted stock awards (2,802) (524)
Net cash, cash equivalents and restricted cash provided by financing activities 129,912 76,295
Net change in cash, cash equivalents and restricted cash 107,931 49,319
Cash, cash equivalents and restricted cash, beginning of period 16,625 1,761
Cash, cash equivalents and restricted cash, end of period 124,556 51,080
Supplemental disclosure of noncash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 5,219 802
Financing costs included in accounts payable and accrued expenses 550 257
Purchases of property and equipment included in accounts payable and accrued expenses 278 0
Reclassification of financial instruments liability to equity $ 11,015 $ 6,120